Sell-Side Consensus
As at 11 February 2021
| 2021 | ||
| H1 | FY | |
| CONTINUING OPERATIONS | ||
| Underlying revenue growth (%) | ||
| John Crane | (9) | (5) |
| Smiths Detection | (7) | (6) |
| Flex-Tek | (2) | (2) |
| Smiths Interconnect | 3 | 3 |
| Continuing Operations | (6) | (4) |
| Revenue (£m) | ||
| John Crane | 427 | 883 |
| Smiths Detection | 340 | 738 |
| Flex-Tek | 237 | 461 |
| Smiths Interconnect | 143 | 312 |
| Continuing Operations | 1,146 | 2,395 |
| Operating profit (£m) | ||
| Continuing Operations | 151 | 350 |
| DISCONTINUED OPERATIONS | ||
| Underlying revenue growth (%) | 2 | 2 |
| Revenue (£m) | 441 | 914 |
| Operating profit (£m) | 93 | 182 |
Continuing Operations excludes Smiths Medical which is accounted for as 'discontinued operations - businesses held for distribution to owners'.
H1 consensus is comprised of 9 analyst forecasts: JP Morgan, Goldman Sachs, Barclays, Credit Suisse, Exane BNP, Morgan Stanley, RBC, Societe Generale, Stifel
FY consensus is comprised of 12 analyst forecasts: JP Morgan, Goldman Sachs, BofA, Barclays, Credit Suisse, Exane BNP, Investec, Liberum, Morgan Stanley, RBC, Societe Generale, Stifel